Production & Manufacturing
BioPharma
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
Production & Manufacturing
End-To-End Solutions in Pharma Logistics Creating Difference
There is no shred of doubt that every stage of the pharmaceutical supply chain happens to be critical if the life-saving drugs are to make...
Articles
Energy efficiency in pure steam generation: How small adjustments can lead to big savings
Pharmaceutical manufacturers face a twofold challenge. They not only have to produce vital medicines faster and more efficiently. They must also reduce energy and media...
Drug Research
China Unveils Innovative Drugs Policy to Boost Development
The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support...
Production & Manufacturing
Role of CDMOs in Outsourced Pharmaceutical Manufacturing
The pharmaceutical sector stands at the crossroads of innovation and is indeed driven by global healthcare demands, advancements within technology, and immediate calls for sustainable...
Business & Industry
Regional Pharma Hubs for Effective Supply Chain Outcomes
It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to...
Packaging & Labelling
Incorporation of Antimicrobial Coatings in Pharmaceuticals
In the very rapidly evolving pharmaceutical spectrum, the safeguarding of injectable biologics happens to be of utmost significance. These delicate products often need strict controls...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.